p tirzepatide cmpd FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now Tirzepatide - Purity and Mass

PubMed CrossRef Kosiborod MN, Petrie MC, Borlaug BA, et al

Clinical studies showed 2-10x increases in GH levels and 1.5-3x increases in IGF-1

Patients should not consider allulose a substitute for prescribed GLP-1 agonist medications or expect comparable therapeutic effects for diabetes management or weight loss

This is a secondary-prevention result, not a general heart-health claim, and it belongs to the full obesity dose

However, regardless of whether it is oral administration or subcutaneous injection, the proportion of adverse events in females is higher than that in males

Insurance coverage is yet another barrier